Mestastop Solutions have raised a third successive round of funding against Compulsorily Convertible Preference Shares (CCPS) that was led by Vistari Venture Partners and other angel investors, two of whom are in a leadership role in Indian Biotech (name withheld …
Mestastop Solutions have partnered with Science Exchange, the globally recognized and respected online marketplace by major biopharmas, to offer their proprietary functional assay platform on metastasis. “We’re pleased to welcome Mestastop Solutions as a Science Exchange Contracted™ provider on our …